Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Insights
Chapter 2 Market Overview
- Overview
- Types of Cell Therapy
- Applications of Cell Therapy
- Regenerative Medicine
- Cancer
- Autoimmune Disorders
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Point-of-Care Manufacturing in CAR-T Therapies
- Growing Demand for Regenerative Medicine
- Market Restraints
- High Costs and Integration Challenges
- Regulatory Uncertainties
- Market Opportunities
- Increasing Startups in Cell Therapy Manufacturing
- Scalable Platforms
Chapter 4 Emerging Technologies and Developments
- Introduction
- Real-Time Monitoring (RTM) of Operations
- Off-the-Shelf Cell Therapies
- Miniaturization of Cell Therapy Systems
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Global Automated and Closed Cell Therapy Market by Automation Type
- Semi-Automated Cell Therapy
- Fully Automated Cell Therapy
- Global Automated and Closed Cell Therapy Market by Cell Type
- CAR-T Cells
- Stem Cells
- Other Cell Types
- Global Automated and Closed Cell Therapy Market by Application
- Market Size and Forecast
- Clinical
- Commercial
- Geographic Breakdown
- Global Market for Automated and Closed Cell Therapy by Region
- Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 6 Competitive Intelligence
- Competitive Landscape
- Partnerships
- Investments and Funding
- Patent Analysis
Chapter 7 Sustainability in the Automated and Closed Cell Therapy Market
- Introduction
- Sustainability in the Automated and Closed Cell Therapy Industry
- Understanding the ESG Data
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks
List of Tables
Summary Table: Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
Table 1: Classification of Stem Cells
Table 2: Comparison Between Autologous and Allogeneic Therapeutics
Table 3: Companies with Off-the-Shelf Therapeutics Pipeline
Table 4: Differences between Semi-Automation and Full Automation in Cell Therapy
Table 5: Global Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 6: Select Semi-Automated Cell Therapy Systems
Table 7: Global Market for Semi-Automated Cell Therapy, by Region, Through 2029
Table 8: Global Market for Semi-Automated Cell Therapy, by Workflow, Through 2029
Table 9: Global Market for Automated and Closed Apheresis, by Region, Through 2029
Table 10: Global Market for Automated and Closed Expansion, by Region, Through 2029
Table 11: Global Market for Automated and Closed Fill-Finish, by Region, Through 2029
Table 12: Global Market for Automated and Closed Separation, by Region, Through 2029
Table 13: Global Market for Other Automated and Closed Workflows, by Region, Through 2029
Table 14: Global Market for Fully Automated Cell Therapy, by Region, Through 2029
Table 15: Global Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 16: FDA-Approved CAR-T Cell Therapies
Table 17: Global Market for Automated and Closed CAR-T Cell Therapy, by Region, Through 2029
Table 18: Global Market for Automated and Closed Stem Cell Therapy, by Region, Through 2029
Table 19: Global Market for Automated and Closed Other Cell Therapies, by Region, Through 2029
Table 20: Global Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 21: Global Market for Clinical Automated and Closed Cell Therapy, by Region, Through 2029
Table 22: Global Market for Commercial Automated and Closed Cell Therapy, by Region, Through 2029
Table 23: Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
Table 24: North American Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 25: North American Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 26: North American Market for Semi-automated Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 27: North American Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 28: North American Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 29: European Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 30: European Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 31: European Market for Semi-Automated Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 32: European Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 33: European Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 34: Asia-Pacific Market for Automated and Closed Cell Therapy, by Country, Through 2029
Table 35: Asia-Pacific Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 36: Asia-Pacific Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 37: Asia-Pacific Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 38: Asia-Pacific Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 39: RoW Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
Table 40: RoW Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
Table 41: RoW Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
Table 42: RoW Market for Automated and Closed Cell Therapy, by Application, Through 2029
Table 43: Top Automated and Closed Cell Therapy Companies, 2023
Table 44: Select Strategic Alliances in the Automated and Closed Cell Therapy Industry, 2022-2024
Table 45: Major Funding Activities in the Automated and Closed Cell Therapy Industry, 2022-2024
Table 46: Active Patents of the Key Competitor Companies, 2022-2024
Table 47: ESG Rankings for Major Automated and Closed Cell Therapy, 2024*
Table 48: ESG: Environmental Overview
Table 49: ESG: Social Overview
Table 50: ESG: Governance Overview
Table 51: Report Sources
Table 52: Glossary of Terms Used in the Automated and Closed Cell Therapy Market
Table 53: Adva Biotechnology: Company Snapshot
Table 54: Adva Biotechnology: Product Portfolio
Table 55: Adva Biotechnology: News/Key Developments, 2024
Table 56: Biospherix Ltd.: Company Snapshot
Table 57: Biospherix Ltd.: Product Portfolio
Table 58: Biospherix Ltd.: News/Key Developments, 2022
Table 59: Cellares: Company Snapshot
Table 60: Cellares: Product Portfolio
Table 61: Cellares: News/Key Developments, 2024
Table 62: Danaher Corp.: Company Snapshot
Table 63: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64: Danaher Corp.: Product Portfolio
Table 65: Danaher Corp.: News/Key Developments, 2024
Table 66: Fresenius SE & Co. KGAA: Company Snapshot
Table 67: Fresenius SE & Co. KGAA: Financial Performance, FY 2022 and 2023
Table 68: Fresenius SE & Co. KGaA: Product Portfolio
Table 69: Fresenius SE & Co. KGAA: News/Key Developments, 2023
Table 70: Lonza: Company Snapshot
Table 71: Lonza: Financial Performance, FY 2022 and 2023
Table 72: Lonza: Product Portfolio
Table 73: Lonza: News/Key Developments, 2022
Table 74: Miltenyi Biotec: Company Snapshot
Table 75: Miltenyi Biotec: Product Portfolio
Table 76: Miltenyi Biotec: News/Key Developments, 2024
Table 77: Sartorius AG: Company Snapshot
Table 78: Sartorius AG: Financial Performance, FY 2022 and 2023
Table 79: Sartorius AG: Product Portfolio
Table 80: Sartorius AG: News/Key Developments, 2024
Table 81: Terumo Corp.: Company Snapshot
Table 82: Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 83: Terumo Corp.: Product Portfolio
Table 84: Terumo Corp.: News/Key Developments, 2024
Table 85: Thermo Fisher Scientific Inc.: Company Snapshot
Table 86: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 87: Thermo Fisher Scientific Inc.: Product Portfolio
Table 88: Thermo Fisher Scientific Inc.: News/Key Developments, 2024
List of Figures
Summary Figure: Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
Figure 1: Types of Cells Used in Cell Therapies
Figure 2: Benefits of Automated and Closed Cell Therapy Manufacturing
Figure 3: Market Dynamics of Global Automated and Closed Cell Therapy Market
Figure 4: Workflow Involved in the Production of CAR-T Therapies
Figure 5: Emerging Technologies in the Automated and Closed Cell Therapy Market
Figure 6: Global Market Shares of Automated and Closed Cell Therapy, by Automation Type, 2023
Figure 7: Global Market for Semi-Automated Cell Therapy, by Region, 2021-2029
Figure 8: Global Market for Fully Automated Cell Therapy, by Region, 2021-2029
Figure 9: Global Market Shares of Automated and Closed Cell Therapy, by Cell Type, 2023
Figure 10: Global Market for Automated and Closed CAR-T Cell Therapy, 2021-2029
Figure 11: Global Market for Automated and Closed CAR-T Cell Therapy, by Region, 2021-2029
Figure 12: Global Market for Automated and Closed Stem Cell Therapy, 2021-2029
Figure 13: Global Market for Automated and Closed Stem Cell Therapy, by Region, 2021-2029
Figure 14: Global Market for Automated and Closed Other Cell Therapies, 2021-2029
Figure 15: Global Market for Automated and Closed Other Cell Therapies, by Region, 2021-2029
Figure 16: Global Market Shares of Automated and Closed Cell Therapy, by Application, 2023
Figure 17: Global Market for Clinical Automated and Closed Cell Therapy, 2021-2029
Figure 18: Global Market for Commercial Automated and Closed Cell Therapy, 2021-2029
Figure 19: Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
Figure 20: Global Market for Automated and Closed Cell Therapy, by Region, 2021-2029
Figure 21: North American Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 22: U.S. Market for Automated and Closed Cell Therapy, 2021-2029
Figure 23: Canadian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 24: Mexican Market for Automated and Closed Cell Therapy, 2021-2029
Figure 25: European Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 26: German Market for Automated and Closed Cell Therapy, 2021-2029
Figure 27: French Market for Automated and Closed Cell Therapy, 2021-2029
Figure 28: Italian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 29: Spanish Market for Automated and Closed Cell Therapy, 2021-2029
Figure 30: U.K. Market for Automated and Closed Cell Therapy, 2021-2029
Figure 31: Rest of Europe Market for Automated and Closed Cell Therapy, 2021-2029
Figure 32: Asia-Pacific Market Shares of Automated and Closed Cell Therapy, by Country, 2023
Figure 33: Chinese Market for Automated and Closed Cell Therapy, 2021-2029
Figure 34: Japanese Market for Automated and Closed Cell Therapy, 2021-2029
Figure 35: Indian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 36: Australian Market for Automated and Closed Cell Therapy, 2021-2029
Figure 37: South Korean Market for Automated and Closed Cell Therapy, 2021-2029
Figure 38: Rest of Asia-Pacific Market for Automated and Closed Cell Therapy, 2021-2029
Figure 39: Snapshot of the ESG Pillars
Figure 40: Advantages of ESG for Companies
Figure 41: ESG Goals of Automated and Closed Cell Therapy Companies
Figure 42: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 43: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 44: Fresenius SE & Co. KGAA: Revenue Share, by Business Unit, FY 2023
Figure 45: Fresenius SE & Co. KGAA: Revenue Share, by Country/Region, FY 2023
Figure 46: Lonza: Revenue Share, by Business Unit, FY 2023
Figure 47: Lonza: Revenue Share, by Country/Region, FY 2023
Figure 48: Sartorius AG: Revenue Share, by Business Unit, FY 2023
Figure 49: Sartorius AG: Revenue Share, by Country/Region, FY 2023
Figure 50: Terumo Corp.: Revenue Share, by Business Unit, FY 2023
Figure 51: Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 52: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 53: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
